The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody-Reference-Cited by-同舟云学术

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

Published:2009-12-16 Issue:3 Volume:49 Page:433-440
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Nakashima Ran,Imura Yoshitaka,Kobayashi Shio,Yukawa Naoichiro,Yoshifuji Hajime,Nojima Takaki,Kawabata Daisuke,Ohmura Koichiro,Usui Takashi,Fujii Takao,Okawa Katsuya,Mimori Tsuneyo

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/49/3/433/17386711/kep375.pdf

Reference37 articles.

1. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies;Yoshifuji;Autoimmunity,2006

2. Amyopathic dermatomyositis: a review;Euwer;J Invest Dermatol,1993

3. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis;Sato;Arthritis Rheum,2005

4. Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders;Mimori;J Biol Chem,1986

5. Aseptic meningitis in mixed connective tissue disease: cytokine and anti-U1RNP antibodies in cerebrospinal fluids from two different cases;Fujita;Mod Rheumatol,2008

Cited by 288 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies;Seminars in Arthritis and Rheumatism;2024-10

2. Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy;Arthritis Research & Therapy;2024-08-22

3. An Adolescent Case of Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis With Interstitial Lung Disease Successfully Treated by Multitarget Therapy Avoiding Cyclophosphamide: A Case Report and Literature Review;Cureus;2024-06-15

4. MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C);eBioMedicine;2024-06

5. Prognostic analysis of MDA5‐associated clinically amyopathic dermatomyositis with interstitial lung disease;Immunity, Inflammation and Disease;2024-06